| Pharmaceutical Information |
| Drug Name |
Fesoterodine |
| Drug ID |
BADD_D00891 |
| Description |
Fesoterodine is an antimuscarinic prodrug for the treatment of overactive bladder syndrome. |
| Indications and Usage |
For the treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence). |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
G04BD11 |
| DrugBank ID |
DB06702
|
| KEGG ID |
D07226
|
| MeSH ID |
C526675
|
| PubChem ID |
6918558
|
| TTD Drug ID |
D00BLL
|
| NDC Product Code |
47621-025; 50370-0047 |
| Synonyms |
fesoterodine | toviaz | fesoterodine fumarate |
|
| Chemical Information |
| Molecular Formula |
C26H37NO3 |
| CAS Registry Number |
286930-02-7 |
| SMILES |
CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2 |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
